← Back to headlines
Lupin Achieves Top Global Pharma Ranking in S&P ESG Assessment 2025
Indian pharmaceutical company Lupin has been recognized as the number one globally in the pharma sector and across all sectors in India in the S&P ESG Assessment for 2025.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
